Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 2/20 | 0.37 |
| ▸ | GALR1 | P47211 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | APP | P05067 | 3/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | ASH1L | Q9NR48 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21149111 | 0.96 | METAP2 (0.42) | METAP2CHRNB4CHRNA3PDE4AGALR1 | |
| Sulfur Dioxide SCHEMBL21462914 | 0.92 | METAP2 (0.40) | METAP2CHRNB4CHRNA3PDE4AGALR1 | |
| SCHEMBL20698262 | 0.88 | KMO (0.37) | APPHTR7BACE1ASH1L | |
| SCHEMBL1032858 | 0.88 | METAP2 (0.44) | METAP2CHRNB4CHRNA3PDE4AGALR1 | |
| SCHEMBL19607480 | 0.84 | BACE1 (0.42) | METAP2CHRNB4CHRNA3PDE4AGALR1 | |
| SCHEMBL29993458 | 0.82 | KMO (0.47) | MGLL | |
| SCHEMBL2562920 | 0.82 | KMO (0.47) | MGLL | |
| SCHEMBL7714897 | 0.82 | BACE1 (0.41) | METAP2CHRNB4CHRNA3PDE4AGALR1 | |
| Iodobenzene SCHEMBL10487194 | 0.81 | ALDH1A1 (0.42) | BACE1 | |
| SCHEMBL23174276 | 0.78 | ALDH1A1 (0.58) | METAP2CHRNB4CHRNA3PDE4AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3763750-B1 | POLYMER, MONOMER, COATING COMPOSITION COMPRISING SAME, AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2023-07-19 | — | — | EP | disclosed |
| US-20220085313-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| CN-100497345-C | 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2009-06-10 | — | — | CN | disclosed |
| CN-1878777-A | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2006-12-13 | — | — | CN | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |